Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals IncfiledCriticalAnadys Pharmaceuticals Inc
Priority to DO2005000111ApriorityCriticalpatent/DOP2005000111A/en
Publication of DOP2005000111ApublicationCriticalpatent/DOP2005000111A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención esta dirigida a los nucleósidos de 3R-D-ribofuranosiltiazolo[4,5-d]pirimidina y las composiciones farmaceuticas que contienen tales compuestos, que tienen actividad inmunomoduladora. La invención esta tambien dirigida al use terapeutico o profilactico de tales compuestos y composiciones, y a los metodos para el tratamiento de enfermedades o trastornos descritos en la presente, mediante la administración de cantidades efectivas de tales compuestos.The invention is directed to the nucleosides of 3R-D-ribofuranosylthiazolo [4,5-d] pyrimidine and the pharmaceutical compositions containing such compounds, which have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to the methods for the treatment of diseases or disorders described herein, by the administration of effective amounts of such compounds.
DO2005000111A2005-06-062005-06-06
NUCLEOSIDS OF 3-BETA-D-RIBOFURANOSILTIAZOLO [4,5-D] PYRIMIDINE AND USES OF THE SAME
DOP2005000111A
(en)